非凯托性高血糖症与可逆皮质失明的临床分析:一个病例报告
Litao Wang1, Wenting Li2, Fengjuan Zhang3
1Department of Neurology and Institute of Neurology, School of Medicine, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, 200025, China.
Journal of medical case reports
|November 28, 2025
概括
非凯托性高血糖症是糖尿病控制不良的并发症,可能会导致神经症状,如脑短视. 早期查和治疗对于管理这种情况和预防误诊至关重要.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 放射学 放射学是一门学科.
背景情况:
- 非凯托性高血糖症是一种与血糖控制不良相关的综合征.
- 它可以表现为神经缺陷,如胆固醇,和头痛.
- 缺乏症状特异性往往导致误诊和延迟治疗.
研究的目的:
- 突出非凯托性高血糖症的诊断和治疗方法.
- 强调在患有特定神经症状的患者中查非凯托性高血糖症的重要性.
主要方法:
- 关于两名患有2型糖尿病和血糖控制不良的男性患者的病例报告.
- 临床表现包括近视和头痛.
- 磁共振成像揭示了特定的大脑信号异常.
主要成果:
- 通过临床,成像和治疗反应评估证实了非凯托性高血糖症的诊断.
- 在控制血糖后,神经症状和成像检查结果完全消失.
- 在六个月的随访期间,没有观察到复发.
结论:
- 在出现突发头痛,视野缺陷,或血胆病的患者中,应考虑非凯托性高血糖症.
- 改善非凯托性高血糖症的诊断灵敏度对于及时干预至关重要.
- 本案例报告强调了有效的临床管理策略.
相关概念视频
Hypoglycemia and Glucagon
778
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
778
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K


